Latest filing published 11 Sept 2013 for Halozyme Therapeutics, INC., €53k.
Insider track record
No signal scores available.
H. Michael Shepard: trading record in brief
H. Michael Shepard is a declared insider of Halozyme Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 15 May 2012 to 19 August 2013, the count stands at 4 filings.
The open-market record consists of 1 sale worth €53k, with no purchase. Besides market trades, the filings include 3 option exercises. 2013 to date brings no purchases and 1 sale.
Most recently, on 11 September 2013, the filings show an open-market sale worth €53k in Halozyme Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to H. Michael Shepard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$7.11Common StockSEC:0001483813-13-000094:0
- 8,290 shares0Common StockSEC:0001483813-13-000013:0
- 3,508 shares0Common StockSEC:0001483813-13-000013:1
- 11,400 shares0Common StockSEC:0001483813-12-000022:0
4 of 4 declarations
